49.97 USD
↘ 0.11 (0.22%)AT CLOSE (03:59 PM EDT)
Travere Therapeutics, Inc. Common Stock
TVTXNASDAQ • USD
49.87
↘ 0.10 (0.19%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
49.87
↘ 0.10 (0.19%)
Market: CLOSED
Travere Therapeutics, Inc. Common Stock (TVTX) trades at $49.96 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TVTX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 26, 2026.
Open?$50.52
High?$51.32
Low?$49.24
Prev. Close?$50.08
Volume?4.6M
Avg. Volume?1.9M
VWAP?$49.92
Rel. Volume?2.39x
Bid / Ask
Bid?$42.44 × 100
Ask?$59.02 × 100
Spread?$16.58
Midpoint?$50.73
Valuation & Ratios
Market Cap?4.7B
Shares Out?94.3M
Float?90.2M
Float %?95.6%
P/E Ratio?N/A
P/B Ratio?192.50
EPS?-$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
Themes
Address
3611 VALLEY CENTRE DR
SAN DIEGO, CA 92130
Phone: 888-969-7879
SAN DIEGO, CA 92130
Phone: 888-969-7879
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?43
Momentum?57
Short Sent.?50
Piotroski F-Score?3/9Weak
Altman Z-Score?2.22Grey
Confidence?72%Moderate
Short InterestHigh
Short % of Float?12.11%High
Short Interest?10.9M
Days to Cover?5.2
Free Float90.2M
Avg Daily Volume2.1M
Settlement Date2026-10-15
Financial Health
Current Ratio?4.05Strong
Quick Ratio?3.99Strong
Cash Ratio?0.77Adequate
Debt/Equity?24.58High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score33/100
P/E?N/A▾
P/B?192.50HIGH▾
Peers100
S&P3
P/S?7.98HIGH▾
Peers100
S&P13
P/FCF?51.1PRICEY▾
Peers100
S&P10
EV/EBITDA?227.2HIGH▾
Peers100
S&P3
EV/Sales?8.80HIGH▾
Peers100
S&P14
Returns & Efficiency
ROE?-177.2%WEAK▾
S&P3
ROA?-5.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$92.5M
Enterprise Value?$5.2B
Fundamentals ratios updated end of day